• Profile
Close

The prevalence of the chimeric TNXA/TNXB gene and clinical symptoms of Ehlers–Danlos syndrome with 21-hydroxylase deficiency

Journal of Clinical Endocrinology & Metabolism May 29, 2020

Gao Y, Lu L, Yu B, et al. - In the present study, the researchers sought to evaluate the prevalence of the chimeric TNXA/TNXB gene and clinical symptoms in a Chinese cohort with 21-hydroxylase deficiency (21-OHD). Participants in the study were 424 patients with 21-OHD who were genetically diagnosed. In order to identify the CAH-X genotype, multiplex ligation-dependent probe amplification and sequencing were used. Clinical features of joints, skin, and other systems have been assessed in 125 patients. Of the 424 patients, 94 had a deletion on at least 1 allele of CYP21A2 and 59 of them harbored the heterozygotic TNXA/TNXB chimera. Approximately 14% of patients with 21-OHD in the study may have chimeric TNXA/TNXB gene mutations and most of them have clinical symptoms associated with EDS. It is important to further examine the association between the CAH-X genotypes and clinical features in connective tissue, such as joint or skin.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay